CASI icon

CASI Pharmaceuticals
CASI

Overview Fund Trends Analyst Outlook Journalist POV

24 hedge funds and large institutions have $6.26M invested in CASI Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

95% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 21

Holders
24
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$82.8K
2
+$8K
3
+$5.39K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.11K
5
Northern Trust
Northern Trust
Illinois
+$456

Top Sellers

1
-$315K
2
-$156K
3
-$126K
4
Citadel Advisors
Citadel Advisors
Florida
-$124K
5
VF
Virtu Financial
New York
-$91K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
1
2